BioCentury
ARTICLE | Finance

Avanir Chronicles

December 15, 2014 8:00 AM UTC

Avanir chroniclesThe $17 takeout price Otsuka Pharmaceutical Co. Ltd. will pay for Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) is only a 13% premium to the neurology play's close the day before the $3.5...